Aurinia Pharmaceuticals to Participate in Two Upcoming Investor Conferences

Rhea-AI Summary

Aurinia Pharmaceuticals (NASDAQ: AUPH) announced participation in two upcoming investor conferences. The RBC Capital Markets Global Healthcare Conference is scheduled for May 19, 2021, at 10:55 a.m. ET, followed by the Oppenheimer Rare & Orphan Disease Summit on May 21, 2021, at 10:45 a.m. ET. Interested parties can access the live audio webcast via the Investors section on Aurinia's website, with a replay available afterward. Aurinia focuses on delivering therapies for serious diseases, including LUPKYNIS™, the first FDA-approved oral treatment for active lupus nephritis.

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that members of the executive management team will participate in two upcoming investor conferences:

• RBC Capital Markets Global Healthcare Conference on Wednesday, May 19, 2021 at 10:55 a.m. ET; and
• Oppenheimer Rare & Orphan Disease Summit on Friday, May 21, 2021 at 10:45 a.m. ET.

In order to participate in the audio webcast, interested parties can access the live webcast under "News/Events” through the “Investors” section of the Aurinia corporate website at www.auriniapharma.com. A replay of the webcast will be available on Aurinia’s website.

ABOUT AURINIA

Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. The Company has introduced LUPKYNIS™ (voclosporin), the first FDA-approved oral therapy dedicated for the treatment of adult patients with active lupus nephritis (LN). The Company’s head office is in Victoria, British Columbia, its U.S. commercial hub is in Rockville, Maryland, and the Company focuses its development efforts globally.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210514005073/en/

FAQ

When is Aurinia Pharmaceuticals participating in investor conferences?

Aurinia Pharmaceuticals will participate in the RBC Capital Markets Global Healthcare Conference on May 19, 2021, at 10:55 a.m. ET, and the Oppenheimer Rare & Orphan Disease Summit on May 21, 2021, at 10:45 a.m. ET.

Where can I watch the Aurinia Pharmaceuticals investor conferences?

The live audio webcasts for Aurinia Pharmaceuticals' conferences can be accessed through the Investors section of their website, with replays available after the events.

What is LUPKYNIS™ by Aurinia Pharmaceuticals?

LUPKYNIS™ (voclosporin) is the first FDA-approved oral therapy specifically for treating adult patients with active lupus nephritis.

What is the stock symbol for Aurinia Pharmaceuticals?

The stock symbol for Aurinia Pharmaceuticals is AUPH, traded on NASDAQ.